Please login to the form below

Not currently logged in
Email:
Password:

Ashfield appoints new UK head of patient solutions

Stephanie Hill strengthens the commercial team at leading healthcare network

Stephanie Hill

Ashfield, a leader in commercialisation services for the healthcare industry, has appointed Stephanie Hill (pictured above) as its new head of patient solutions in the UK. 

She has over 17 years of experience in the healthcare industry, having first joined Ashfield in 2002 as a nurse advisor.

Since then, she has worked across a number of therapy areas, and supported patients with long term conditions and rare diseases.

Following a stint of working in client and provider roles, Hill re-joined Ashfield in 2016 as an international programme director.

In that role, she supported the design, implementation and management of patient support programmes for various brand launches across Europe.

She has also worked with many key opinion leaders (KOLs) and facilitated advisory boards to aid the delivery of new models of patient care pathways, and was the winner of the PMEA 2013 ‘Best Homecare Programme’ award.

“Following our investment in Salesforce Health Cloud, our Patient Solutions offering for our clients is stronger than ever. I’m looking forward to working with Steph to further differentiate our offering in line with our client’s needs,” said Mick O’Leary, regional president for Ashfield Commercial and Patient Solutions.

20th November 2019

From: Marketing

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ experience, Innovative Trials deploys “boots-on-the-ground”...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...